Pedro A. Piedra, MD
- Infectious Disease
Professor, Departments of Molecular Virology and Microbiology; Pediatrics; Pharmacology
Baylor College of Medicine
Director, CLIA Certified Respiratory Virus Diagnostic Laboratory, Baylor College of Medicine
Phone:
832-824-4330
Phone:
713-798-5240
Languages: English, Spanish
Departments:
Get to know Pedro A. Piedra, MD
Personal Statement
I currently do not actively provide medical care to children. All my time is devoted to research, in particular, in the area of translational research in respiratory viruses.
Clinical Interests
Pediatric infectious diseases
Education
,
,
,
Organizations
,
,
,
,
,
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Research interests
I am a pediatric infectious disease specialist and physician-scientist with an independent research program in respiratory virus research. I have extensive experience in conducting preclinical, translational, and clinical research with a focus on the development of control measures for viral respiratory pathogens such as influenza and respiratory syncytial virus (RSV), and other common respiratory viral agents. I have been mentoring graduate students, post-doctoral fellows, and physicians in basic science and in translational and clinical research for over 30 years. My current research areas are molecular epidemiology of RSV, immune correlates of RSV disease, viral surveillance data on moderate to severe acute respiratory illness in children, the role of respiratory viruses in febrile infants less than 90 days old, clinical significance of respiratory viral infections in pregnant women, bronchiolitis and its relation to asthma, biomarkers of acute respiratory viral disease, and prevention of RSV disease through vaccine and drug development. We have a well-funded research program supported by NIH, CDC, and Industry.